Share
Neumora Therapeutics
Robbins LLP is Investigating Allegations that Neumora Therapeutics, Inc. (NMRA) Misled Investors in the Offering Documents in Support of its IPO
Format
JPEGSource
Robbins LLPDownloads
About Us
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases, financial disclosures and multimedia content to media, investors, and consumers worldwide.
© 2025 Digital Media Innovations, LLC. All rights reserved.